MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-BR-37-0001516
Aster Medicines Private Limited - pharma in Patna, Bihar, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13 Cr
▲ 20% YoY
Net profit · FY 2025
₹14.89 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹73.34 Lakh
EBITDA margin 5.6%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹1.25 Cr
Issued & subscribed
Open charges
₹6.16 Cr
Secured borrowings
Company age
18 yrs
Est. 2008
Directors on board
2
As per MCA filings
About Aster Medicines Private Limited
Data last updated:
Aster Medicines Private Limited is a private limited company based in Patna, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 September 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24230BR2008PTC013937. Its GSTIN is 10AAHCA4085D1Z7 (Bihar).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.25 Cr. It is led by directors Rupesh Anand (Managing Director) and Rishi Anand.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at North Of Janta Hotel Ist Floor Govind Mitra Road, Patna, Bihar, India – 800004.
As per the financials filed for FY 2025, the company reported a revenue of ₹13 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹14.89 Lakh (net margin 1.1%) and EBITDA of ₹73.34 Lakh (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 84% over three years and 61% over five years.
As per MCA filings, the company has open charges of ₹6.16 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Aster Medicines Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-37-0001516). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website astermedicines.com.
Company details
CIN U24230BR2008PTC013937
Registration Number 013937
Incorporation Date 17 September 2008
ROC Patna
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-BR-37-0001516
Recognitions & Rankings of Aster Medicines
Contact details
Aster Medicines Private Limited's registered office is in Patna, Bihar. Its website is astermedicines.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNorth Of Janta Hotel Ist Floor Govind Mitra Road, Patna, Bihar, India – 800004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aster Medicines Private Limited, buy the company report.
Comprehensive company report
Aster Medicines Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aster Medicines is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aster Medicines Private Limited, buy the company report.
Financials of Aster Medicines Private Limited
FY 2025 filings availableAster Medicines Private Limited reported revenue of ₹13 Cr (up 20% YoY) for FY 2025.
Revenue · FY 2025
₹13 Cr ▲ 20%
Net profit · FY 2025
₹14.89 Lakh margin 1.1%
EBITDA · FY 2025
₹73.34 Lakh margin 5.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 84%
5 years · compounded
▲ 61%
EBITDA CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 54%
5 years · compounded
▲ 67%
Revenue has grown at a compounded annual rate (CAGR) of 61% over five years, including 20% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹73.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aster Medicines Private Limited, buy the company report.
Board of directors of Aster Medicines Private Limited
Aster Medicines has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishi Anand | Director | 23 Oct 2020 | 6 Years 0 Months | Current |
| Rupesh Anand | Managing Director | 17 Sep 2008 | 18 Years 1 Months | Current |
Peer comparison
Aster Medicines Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SLB Pharma Private Limited | ₹13.1 Cr (FY 2025) | 78.0% | Telangana, India | |||
| Meddoxx Pharmaceuticals Private Limited | ₹13.03 Cr (FY 2025) | 14.0% | Kozhikode, Kerala, India | |||
| Aster Medicines Private Limitedthis company | ₹13 Cr (FY 2025) | ₹14.89 Lakh | 1.1% | 20.0% | Patna, Bihar, India | |
| Middle Mist Pharmaceuticals Private Limited | ₹12.96 Cr (FY 2025) | -6.0% | Chennai, Tamil Nadu, India | |||
| Galen Pharmaceuticals Limited | ₹12.87 Cr (FY 2025) | -15.0% | Vadodara, Gujarat, India | |||
| C and C Organics Private Limited | ₹12.84 Cr (FY 2025) | 31.0% | Delhi, India |
To see the full peer comparison of Aster Medicines Private Limited, buy the company report.
Auditor
Aster Medicines Private Limited is audited by SATENDRAKUMAR for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SATENDRAKUMAR | FY 2023 | 510200 |
Shareholding
The shareholding of Aster Medicines Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aster Medicines Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6.16 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Aug 2025 | 101139194 | Sidbi | ₹50 Lakh | Open | |
| 19 Sep 2024 | 100985040 | Sidbi | ₹60 Lakh | Open | |
| 18 May 2023 | 100722552 | Sidbi | ₹1.85 Cr | Open | |
| 30 Dec 2021 | 100516047 | Sidbi | ₹10.5 Lakh | Open | |
| 15 Jul 2021 | 100461618 | Sidbi | ₹10 Lakh | Open |
To see the full charge records of Aster Medicines Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Aster Medicines Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Patna, Bihar | Court case (Cr. Case Complaint (O)) | Filed against the company by State of Bihar Through Jitendra Kumar Sinha | Pending |
To see the full case history of Aster Medicines Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aster Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aster Medicines has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCA4085D1Z7 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aster Medicines Private Limited, buy the company report.
Recent activity
Aster Medicines Private Limited has 6 board changes on record since 2008: 3 appointments and 3 cessations. The latest: Rakhi Anand ceased to be Director on 10 Apr 2023.
AGM
Aster Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Sidbi of Rs. 1.85 Cr registered on 18 May 2023 with Charge ID 100722552 was modified on 25 Sep 2025.
Charges
A charge with Sidbi amounted to Rs. 0.50 Cr with Charge ID 101139194 was registered on 06 Aug 2025.
Filing
Aster Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna.
Charges
A charge with Sidbi amounted to Rs. 0.60 Cr with Charge ID 100985040 was registered on 19 Sep 2024.
Charges
A charge with Sidbi amounted to Rs. 1.85 Cr with Charge ID 100722552 was registered on 18 May 2023.
Ceased
Rakhi Anand ceased to be Director.
Charges
A charge with Sidbi amounted to Rs. 0.11 Cr with Charge ID 100516047 was registered on 30 Dec 2021.
Ceased
Premsheela Devi ceased to be Director.
Charges
A charge with Sidbi amounted to Rs. 0.10 Cr with Charge ID 100461618 was registered on 15 Jul 2021.
Charges
A charge with Sidbi amounted to Rs. 3.00 Cr with Charge ID 100414067 was registered on 15 Feb 2021.
Appointed
Rishi Anand was appointed as Director.
4 earlier events are in the company report.
Frequently asked questions
Aster Medicines is an active private limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 September 2008 (18+ years old) and is registered under CIN U24230BR2008PTC013937.
Aster Medicines has 2 current directors:
- Rupesh Anand - Managing Director
- Rishi Anand - Director
The latest financial statements of Aster Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aster Medicines is 10AAHCA4085D1Z7, registered in Bihar.
The CIN (Corporate Identification Number) of Aster Medicines is U24230BR2008PTC013937. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aster Medicines has 1 court case on record: 1 filed against it. 1 is pending.
Aster Medicines was incorporated on 17 September 2008, making it 18+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Aster Medicines by revenue are SLB Pharma Private Limited, Meddoxx Pharmaceuticals Private Limited, Middle Mist Pharmaceuticals Private Limited, Galen Pharmaceuticals Limited, C and C Organics Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rakhi Anand ceased to be Director on 10 Apr 2023. Premsheela Devi ceased to be Director on 01 Dec 2021. Rishi Anand was appointed as Director on 23 Oct 2020. Aster Medicines has 6 board changes on record in total.
Yes, Aster Medicines is registered as a small enterprise under Udyam registration (number: UDYAM-BR-37-0001516).
Aster Medicines can be reached through the website astermedicines.com. Its registered office is in Patna, Bihar, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages